COVID-19 vaccination for pregnant women: strategies for enhanced coverage
DOI:
https://doi.org/10.47203/IJCH.2021.v33i03.025Keywords:
COVID-19, Vaccination registry, Pregnant WomenAbstract
Following the recommendations from the National Technical Advisory Group (NTAG) on Immunization, the Government of India approved three vaccines – an inactivated vaccine, Covaxin and two non-replicating vector-based vaccines, Covishield and Sputnik V for restricted use in an emergency for pregnant women.(1)The late approval of vaccination of pregnant women was due to a lack of evidence, because pregnant women were excluded from previous COVID vaccination trials. The restricted use of this vaccine recommended by NTAG also complies with the regulations of the Centers for Disease Control and Prevention (CDC), the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics. (2-4)
Downloads
References
Government of India. Ministry of Health and family welfare. Operational Guidance for COVID-19 Vaccination of Pregnant Women.July 2021. Available from:https://www.mohfw.gov.in/pdf/OperationalGuidanceforCOVID19vaccinationofPregnantWoman.pdf. (Accessed on 25/09/2021)
Centres for Disease Control and Prevention. COVID-19 vaccines: interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. 2021 https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html. (Accessed on 25/09/2021)
American College of Obstetricians and Gynecologists. Vaccinating pregnant and lactating patients against COVID-19: practice advisory. December 2020 https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients -against-covid-19. (Accessed on 25/09/2021)
American Academy of Pediatrics. Interim guidance for COVID-19 vaccination in children and adolescents. 2021 https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/interim-guidance-for-covid-19-vaccination-in-children-and-adolescents/.(Accessed on 25/09/2021)
Allotey J, Stallings E, Bonet M. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020;370:m3320.
Zambrano LD, Ellington S, Strid P. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status — United States, January 22– October 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1641-
Shimabukuro TT, Kim SY, Myers TR. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med 2021;384:2273-82
V-safe COVID-19 vaccine pregnancy registry. Atlanta: Centers for Disease Control and Prevention. May 3, 2021 https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafepregnancyregistry.html.(Accessed on 25/09/2021)
Statista research Department, 2021. Available: Cumulative number of COVID-19 vaccine doses administered across states and union territories in India as of July 21, 2021 (Accessed on 25/09/2021)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Indian Journal of Community Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
